DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

company name or ticker

Regeneron Beats on Q4 Earnings Driven by Eylea Sales - Analyst Blog

Will Kforce (KFRC) Earnings Surprise on Improving Business? - Analyst Blog

Will Republic Services (RSG) Surprise on Q4 Earnings This Season? - Analyst Blog

AstraZeneca plc Beefs Up Precision Medicine Arsenal

AstraZeneca upped the ante in precision medicine with the announcement of four new collaborations.

Can Gilead Boost HCV Sales with Health Service Deals? - Analyst Blog

Can Cerner (CERN) Surprise Earnings Estimates in Q4? - Analyst Blog

Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog

Gilead Tops Q4 Earnings Estimates, 2015 Outlook Disappoints - Analyst Blog

Will Stericycle (SRCL) Q4 Earnings Beat on Organic Growth? - Analyst Blog

Why Isis Pharmaceuticals, Inc. Shares Exploded Higher By 11% in January

Isis Pharmaceuticals' stock rockets higher in January following a bevy of positive press releases. Find out whether this phenomenal run in Isis can continue or if it'll soon fizzle out.
See More Articles...